says Dr. Mario Gaudino, a cardiothoracic surgeon at Weill Cornell Medicine and NewYork-Presbyterian Hospital, director for the Joint Clinical Trials Office at Weill Cornell Medicine and assistant ...

Minimizing blood loss is "an actionable target to improve operative mortality in women after CABG and reduce the sex gap," wrote a team led by Dr. Mario Gaudino. He's a professor of cardiothoracic ...

There are several situations where the only way for a patient to receive a brand-new intervention, drug or device is participation in a clinical trial, says Dr. Mario Gaudino, a cardiothoracic ...